Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Antipressan 25mg tablets
0204000E0BEACAG
|
Antipressan | Atenolol | Cardiovascular System | No data available |
|
Antipressan 50mg tablets
0204000E0BEAAAB
|
Antipressan | Atenolol | Cardiovascular System | No data available |
|
Antithrombin alfa 1,750unit inf vials
0211000AAAAAAAA
|
Antithrombin alfa | Antithrombin alfa | Cardiovascular System | No data available |
|
Apo-Hydralazine 10mg tablets
0205010J0BCAABK
|
Apo-Hydralazine | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Apresoline 20mg powder for solution for injection ampoules
0205010J0BBACAK
|
Apresoline | Hydralazine hydrochloride | Cardiovascular System | No data available |
|
Aprinox 5mg tablets
0202010B0BBABAC
|
Aprinox | Bendroflumethiazide | Cardiovascular System | No data available |
|
Aprotinin 1,000,000 Kallikrein inactivator units/100ml inf
0211000H0AAAFAF
|
Aprotinin (Antifibrinolytic) | Aprotinin | Cardiovascular System | No data available |
|
Aprotinin 2,000,000 Kallikrein inactivator units/200ml inf
0211000H0AAAGAG
|
Aprotinin (Antifibrinolytic) | Aprotinin | Cardiovascular System | No data available |
|
Aprotinin 500,000 Kallikrein inactivator units/50ml inf
0211000H0AAAEAE
|
Aprotinin (Antifibrinolytic) | Aprotinin | Cardiovascular System | No data available |
|
Aqumeldi 1mg orodispersible tablets
0205051I0BFABCE
|
Aqumeldi | Enalapril maleate | Cardiovascular System | No data available |
|
Aramine 10mg/1ml solution for injection ampoules
0207020L0BBAAAB
|
Aramine | Metaraminol | Cardiovascular System | No data available |
|
Arixtra 1.5mg/0.3ml inj pre-filled syringes
0208010ABBBAEAE
|
Arixtra | Fondaparinux sodium | Cardiovascular System | No data available |
|
Asasantin Retard capsules
0209000V0BBAAAA
|
Asasantin | Dipyridamole and aspirin | Cardiovascular System | No data available |
|
Aspirin 100mg/5ml oral liquid
0209000A0AAA5A5
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 150mg / Isosorbide mononitrate 60mg MR tab
0206010W0AAABAB
|
Isosorbide mononitrate/aspirin | Isosorbide mononitrate with aspirin | Cardiovascular System | No data available |
|
Aspirin 15mg/5ml oral liquid
0209000A0AABHBH
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 225mg/5ml oral liquid
0209000A0AABJBJ
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 25mg capsules
0209000A0AAATAT
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 25mg/5ml oral liquid
0209000A0AABABA
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 30mg/5ml oral liquid
0209000A0AABFBF
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 37.5mg oral powder sachets
0209000A0AACCCC
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 37.5mg/5ml oral liquid
0209000A0AABIBI
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 40mg oral powder sachets
0209000A0AACDCD
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 40mg/5ml oral liquid
0209000A0AABBBB
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
|
Aspirin 50mg/5ml oral liquid
0209000A0AABEBE
|
Aspirin (Antiplatelet) | Aspirin | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.